Akari Therapeutics Company Insiders

Akari Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (1.7283) % which means that it has lost $1.7283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.8143) %, meaning that it created substantial loss on money invested by shareholders. Akari Therapeutics' management efficiency ratios could be used to measure how well Akari Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Akari Therapeutics' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 45.89 in 2024, whereas Return On Tangible Assets are likely to drop (2.42) in 2024. At this time, Akari Therapeutics' Other Current Assets are fairly stable compared to the past year. Tangible Asset Value is likely to rise to about 5.9 M in 2024, whereas Total Assets are likely to drop slightly above 4.1 M in 2024. Common Stock Shares Outstanding is likely to drop to about 4.7 M in 2024. Net Loss is likely to drop to about (21 M) in 2024

Akari Therapeutics Workforce Comparison

Akari Therapeutics Insider Trading

Akari Therapeutics Notable Stakeholders

The success or failure of an entity such as Akari Therapeutics PLC often depends on how effective the management is. Akari Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Akari management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Akari management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Akari Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Akari Therapeutics PLC. Check Akari Therapeutics' Beneish M Score to see the likelihood of Akari Therapeutics' management manipulating its earnings.

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.